| Literature DB >> 32164202 |
Karen Fong1, Kaiwen Mu1, Jean-Guillaume Rheault2, Roger C Levesque2, David D Kitts1, Pascal Delaquis3, Lawrence Goodridge4, Siyun Wang1.
Abstract
Bacteriophages have shown promise as therapeutic alternatives to antibiotics for the control of infectious bacteria, including the human pathogen Salmonella. However, the development of effective phage-based applications requires the elucidation of key interactions between phages and target hosts, particularly since host resistance to phage is inevitable. Little is known about the alteration of host phenotypes following the development of resistance to phage. The aim of this study is to evaluate the antibiotic susceptibility and virulence of a Salmonella isolate following the development of resistance to bacteriophage SI1. We observed enhanced susceptibility to tetracycline and decreased invasion capacity in a differentiated Caco-2 intestinal cell line. Whole genome sequence analysis revealed an array of mutations, most notably, truncations in vgrG1_2, a core gene involved in Type VI secretion and mutations in the lipopolysaccharide, thereby indicating the plausible attachment site of phage SI1. These findings shed light on understanding the underlying mechanism for phage immunity within the host. Importantly, we reveal an associated genetic cost to the bacterial host with developing resistance to phages. Taken together, these results will aid in advancing strategies to delay or eliminate the development of host resistance when designing informed phage-based antimicrobials.Entities:
Keywords: Salmonella; antibiotic resistance; phage resistance; virulence
Mesh:
Substances:
Year: 2020 PMID: 32164202 PMCID: PMC7084636 DOI: 10.3390/ijms21051883
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Mutations in genes involved in lipopolysaccharide synthesis and type VI secretion system of the S. Agona bacteriophage-insensitive mutants (BIMs). Mutations presented possess a minimum quality score of 20 and a minimum mapping coverage of 8.
| Affected Gene | Putative Function | Strand | nt Position a | Strain | Mutation | Sequence b | Impact on Polypeptide Synthesis |
|---|---|---|---|---|---|---|---|
|
| O-antigen ligase | + | 425 | WT | 3 bp insertion | G------A | Insertion |
| Δ95 | GGATA | ||||||
| Δ96 | GGATA | ||||||
| + | 429 | WT | Substitution | G | None | ||
| Δ95 | G>A | ||||||
| Δ96 | G>A | ||||||
| + | 442 | WT | 4 bp insertion | T-------A | Frameshift | ||
| Δ95 | TGGGA | ||||||
| Δ96 | TGGGA | ||||||
|
| Lipopolysaccharide core heptose (II) kinase | - | 514 | WT | 23 bp insertion | A---------------------------------------------- A | Frameshift |
| Δ95 | AGCGAAGCCCTAAACTTGTTAAAAA | ||||||
| Δ96 | AGCGAAGCCCTAAACTTGTTAAAAA | ||||||
| - | 538 | WT | Substitution | T | Asn --> Lys | ||
| Δ95 | T>G | ||||||
| Δ96 | T>G | ||||||
|
| Actin cross-linking toxin, structural tip protein, involved in type VI secretion | + | 792 | WT | 6 bp insertion | T------------- | Frameshift |
| Δ87 | TCAAGGA | ||||||
| Δ95 | TCAAGGA | ||||||
| Δ96 | TCAAGGA | ||||||
| Δ99 | TCAAGGA | ||||||
| Δ102 | TCAAGGA | ||||||
| + | 798 | WT | Multi-nucleotide substitution | ATTTT | Leu --> Phe | ||
| Δ87 | ATTT>CGGCC | ||||||
| Δ95 | ATTT>CGGCC | ||||||
| Δ96 | ATTT>CGGCC | ||||||
| Δ99 | ATTT>CGGCC | ||||||
| Δ102 | ATTT>CGGCC | ||||||
| + | 810 | WT | 4 bp insertion | A---------T | Frameshift | ||
| Δ95 | AGAACT | ||||||
| Δ96 | AGAACT | ||||||
| + | 816 | WT | 2 bp insertion | T----C | Frameshift | ||
| Δ95 | TCAC | ||||||
| Δ96 | TCAC | ||||||
| + | 820 | WT | Substitution | G | Gly --> Arg | ||
| Δ95 | G>C | ||||||
| Δ96 | G>C | ||||||
| + | 823 | WT | Substitution | G | Gly --> Stop codon | ||
| Δ95 | G>T | ||||||
| Δ96 | G>T | ||||||
| + | 825 | WT | Substitution | A | None | ||
| Δ95 | A>G | ||||||
| Δ96 | A>G | ||||||
| + | 828 | WT | 3 bp deletion | AGGA | Deletion | ||
| Δ95 | A------ | ||||||
| Δ96 | A------ | ||||||
| + | 831 | WT | Substitution | C | Asp --> Glu | ||
| Δ95 | C>G | ||||||
| Δ96 | C>G | ||||||
| + | 836 | WT | Substitution | C | Ala --> Glu | ||
| Δ95 | C>A | ||||||
| Δ96 | C>A |
a relative to wild-type strain. nt: nucleotide. b presented in 5′ to 3′ direction. In substitutions, alternate sequences are preceded by the original sequence and separated with a “>” symbol.
Minimum inhibitory concentrations of the S. Agona strains. Minimum inhibitory concentrations (MICs) were determined by conducting each test in triplicate.
| Strain | MIC (µg/mL) | ||
|---|---|---|---|
| SXT a | TET | SUF | |
| Wild type | 180/3500 | 128 | 2048 |
| ∆87 | 180/3500 | 128 | 2048 |
| ∆95 | 180/3500 | 128 | 2048 |
| ∆96 | 180/3500 | 76.8 | 2048 |
| ∆99 | 180/3500 | 128 | 2048 |
| ∆102 | 180/3500 | 128 | 2048 |
a Values refer to the MICs of sulfamethoxazole and trimethoprim, respectively.
Caco-2 cell adherence of S. Agona strains. The adherence assay was conducted in triplicate and are represented as means ± SD. Means of the BIMs were compared to that of the WT. Different letters indicate significance below α = 0.05.
| Strain | Total Cells Adhered (log CFU ± SD) |
|---|---|
| WT | 6.22 ± 0.23 A |
| ∆87 | 6.65 ± 0.33 A |
| ∆95 | 6.28 ± 0.21 A |
| ∆96 | 6.01 ± 0.19 A |
| ∆99 | 6.48 ± 0.38 A |
| ∆99 | 6.56 ±0.44 A |
Figure 1Caco-2 cell invasion capacity by the S. Agona strains. Error bars indicate the standard deviations of the means of three biological replicates. Means of the BIMs were compared to that of the WT. Asterisks located above mean values indicate significance below α = 0.05 (one-way ANOVA).
Figure 2Schematic representation of the T6SS gene cluster in S. Agona FSL S5-517. Arrows indicate direction of transcription. Black arrows indicate gene products involved in the T6SS. Grey arrows represent gene products of unknown function but believed to play a role in the T6SS. White arrow indicates a hypothetical protein.